LifePoint Health, Inc. announced unaudited consolidated earnings results for second quarter and six months ended June 30, 2017. For the quarter, the company reported revenues of $1,594.8 million, income before income taxes of $70.4 million, net income of $46 million, net income attributable to the company of $42.5 million or diluted per share of $1.03, net cash provided by operating activities of $110.6 million, purchases of property and equipment of $89.2 million, Adjusted EBITDA of $192.2 million compared to the revenues of $1,592.4 million, income before income taxes of $30.4 million, net income of $20.1 million, net income attributable to the company of $16.9 million or diluted per share of $0.38, net cash provided by operating activities of $66.4 million, purchases of property and equipment of $70.3 million, Adjusted EBITDA of $175.4 million for the same quarter a year ago. Capital expenditure for the quarter was $89.2 million.

For the year to date, the company reported revenues of $3,225 million, income before income taxes of $166.4 million, net income of $110 million, net income attributable to the company of $102.4 million or diluted per share of $2.49, net cash provided by operating activities of $202.3 million, purchases of property and equipment of $157.7 million, Adjusted EBITDA of $387.8 million compared to the revenues of $3,173.1 million, income before income taxes of $67 million, net income of $44 million, net income attributable to the company of $38.5 million or diluted per share of $0.87, net cash provided by operating activities of $155.1 million, purchases of property and equipment of $122.9 million, Adjusted EBITDA of $337 million for the same period a year ago. Capital expenditure was 157.7 million.

For the year 2017, the company expects net revenue in the range of $6.425 billion to $6.5 billion, Adjusted EBITDA of $775 million to $795 million, Adjusted Diluted EPS of $3.92 to $4.20. Company expects the full year spend on capital expenditures to be in the range of $475 million to $500 million.